Virtual Medical Affairs Audits: A Viable Alternative

11/17/2022

Diligent’s COO, Denise Dixon, and Director of Quality & Compliance, Alena Galante, author “Virtual Medical Affairs Audits: A Viable Alternative”, recently published by Pharmaceutical Executive.


Prior to COVID-19, audits by Life Sciences companies of their Medical Affairs functions were mostly conducted in person. The pandemic forced companies to look for other ways to meet their audit obligations, and a virtual (remote) approach was generally seen as preferable to delaying the audit. The virtual approach is now firmly established as a viable alternative, even with the easing of COVID restrictions.

This article addresses:

  • The inherent challenges with virtual audits and how to overcome them
  • Planning for a successful virtual audit
  • Sharing and storing of audit documents

 

We hope you find it to be of value.